Refractory adult-onset Still’s disease complicated with monoclonal gammopathy of undetermined significance: A case report

Author:

Saito Kenji1,Asano Tomoyuki1,Matsumoto Haruki1,Fujita Yuya1,Matsuoka Naoki1,Ohkawara Hiroshi2,Sumichika Yuya1,Yoshida Shuhei1,Temmoku Jumpei1,Yashiro-Furuya Makiko1,Sato Shuzo1,Watanabe Hiroshi1,Migita Kiyoshi1

Affiliation:

1. Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan

2. Department of Hematology, Fukushima Medical University School of Medicine, Fukushima, Japan.

Abstract

Rationale: Adult-onset Still’s disease (AOSD) is a rare inflammatory disease characterized by a classic triad of daily spike fever, arthritis, and a typical salmon-pink rash. The involvement of inflammatory cytokines by various factors such as infection, drug, or neoplasm causes refractory AOSD. Patient concerns: We report a 63-year-old man with a high fever, rash, hyperferritinemia, and M proteinemia. His serum levels of interleukin-6 and interleukin-18 were remarkably high at 192 and 114,250 pg/mL, respectively. Diagnosis: AOSD complicated with monoclonal gammopathy of undetermined significance was diagnosed. Interventions: After steroid pulse therapy followed by oral prednisolone, cyclosporin, methotrexate, and colchicine, serum ferritin levels temporarily declined, but secondary cytomegalovirus infections exacerbated AOSD’s activity. Outcomes: Finally, after tocilizumab induction, AOSD activity was gradually suppressed over a long period. Lessons: The disease activity of AOSD is exacerbated by multiple factors, including comorbidities or infections. Clinicians need to consider that monoclonal gammopathy of undetermined significance complications might become AOSD refractory by an elevation of the inflammatory cytokines. Moreover, further prospective studies are required to confirm this result.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Colchicine;Reactions Weekly;2023-01-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3